Gov. McCrory appoints three to N.C. Biotech Center board
Research Triangle Park, N.C. —
The state-funded Biotech Center supports biotechnology research, business and education, the progress of biotechnology from research to commercialization in North Carolina. The center also supports the growth of biotechnology in North Carolina, including job growth.
Each of the board appointments is for two years. Art Pappas, founder of Durham venture capital firm Pappas Ventures, was reappointed to the board by McCrory. Joining Pappas on the Biotech Center’s board are Carol Marino, managing director for Syngenta Ventures, the venture arm of agricultural biotech company Syngenta and Dr. Bhaskar Venepalli, president and CEO of CiVentiChem, an R&D services company.
Please Log In to add a comment.
Best of TechWire Insider
- Star Trek gets real: Durham startup delivers interactive holograms
- Every tech company needs to join 'Global Government Surveillance Reform' movement
- Durham entrepreneurs find ally in Charlotte medtech incubator
- GoGown deal shows power, necessity of networking for startups
- New GSK oncology consortium targets combination therapies
- Fighting hospital infections: A Durham nurse's dream produces the GoGown
- From photos to out-of-this-world art: Raleigh firm's software transforms images
- LabCorp expands gene tests for cancer - but don't confuse these with 23andMe
- ChannelAdvisor: Mobile cuts deeply into PC share of online shopping
- Inside Appia's latest funding deal: Debt beats dilution